Stratos Wealth Partners, Ltd. Bristol Myers Squibb CO Transaction History
Stratos Wealth Partners, Ltd.
- $6.9 Billion
- Q4 2024
A detailed history of Stratos Wealth Partners, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 217,900 shares of BMY stock, worth $12.2 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
217,900
Previous 222,909
2.25%
Holding current value
$12.2 Million
Previous $11.5 Million
6.84%
% of portfolio
0.18%
Previous 0.17%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,690Shares Held
1.53BCall Options Held
32MPut Options Held
35.4M-
Vanguard Group Inc Valley Forge, PA190MShares$10.7 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.91 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.39 Billion0.44% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.22 Billion0.2% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.39 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...